A New Generation of Meglitinide Oral Hypoglycemic Agents

A new generation of meglitinide oral hypoglycemic agents----Mitiglinide Calcium Tablets 

Specification：5mg*15pieces*2

Oral Hypoglycemic DrugsPatients can take it orally.

Indications:

Improve postprandial hyperglycemia in patients with type 2 diabetes (only for diabetics, exercise therapy can not effectively control blood glucose in patients with diet, exercise therapy based on the addition of α-glucosidase inhibitors can not effectively control the blood sugar patient).

Dosage:

5 minutes before the meal orally. Usually adult 10mg (2 tablets), 3 times a day. According to the patient's treatment effect, as appropriate, adjust the dose.

We are one of the leading China manufacturers and suppliers of a new generation of meglitinide oral hypoglycemic agents. Should you're interested in it, welcome to buy or wholesale the quality and cheap products made in China from our factory. We have many products in stock and the low price, free sample and the customized service are available.